Otto Krieger

6.1k citations
37 papers · 1.5k indexed · 1 hit paper · h-index 14

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 2%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 18
    • Chronic Myeloid Leukemia Treatments 4
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 8
    • Chronic Lymphocytic Leukemia Research 3

Otto Krieger

34 papers receiving 1.5k citations

Hit Papers

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients 2007 · 540 citations
5402007202620132019100200300400500

Peers

Otto Krieger
Comparison fields: 5 of 71
  • Hematology 1.2k
  • Genetics 528
  • Emergency Medicine 171
  • Pathology and Forensic Medicine 197
  • Oncology 271
Replace Thomas Nösslinger with:
Thomas Nösslinger Austria
Martin Jädersten Sweden
Andrea Kündgen Germany
Andrea Kuendgen Germany
Hartmut Doehner Germany
Ingunn Dybedal Norway
Thomas Cluzeau France
Pascale Lepelley France
FR Davey United States
Sefer Gezer United States
Otto Krieger relative to Thomas Nösslinger Austria Thomas Nösslinger's profile →
Citations per field
00.5×1.5×
Thomas Nösslinger · 1×
Citations per year

Countries citing papers authored by Otto Krieger

Since Specialization
Citations

This map shows the geographic impact of Otto Krieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Krieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Krieger more than expected).

Fields of papers citing papers by Otto Krieger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otto Krieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Krieger. The network helps show where Otto Krieger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Otto Krieger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Otto Krieger Line = papers co-authored together Otto Krieger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20141
2 201416
3 20122
4 20102
5 200948
6 20094
7 20088
8 200827
9 20074
10 200713
11 20071
12 20067
13 20056
14 20043
15 200234
16 200249
17 20009
18 199323
19 19921
20 198918

About Otto Krieger

Otto Krieger is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Emergency Medicine and Public Health, Environmental and Occupational Health, having authored 37 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Eosinophilic Disorders and Syndromes (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (528 citations), Emergency Medicine (171 citations), Pathology and Forensic Medicine (197 citations) and Oncology (271 citations). Otto Krieger has collaborated with scholars based in Austria, Germany and Japan. Frequent co-authors include Peter Valent, Reinhard Stauder, Michael Pfeilstöcker, Detlef Haase, Christa Fonatsch, Thomas Nösslinger, Friedrich Wimazal, Aristoteles Giagounidis, Christian Steidl and Julie Schanz. Their work appears in journals such as Blood, Leukemia Research, Annals of Hematology, British Journal of Haematology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026